New platform will speed-develop drugs to combat future COVID-19 variants
A Hebrew University startup has developed a new drug platform for speedily generating anti-viral drugs that target proteins common to all viruses.
Nano-antibodies [in purple] settle on the spike of the corona virus.(photo credit: Photo from Dr. Dina Schneidemann's laboratory)ByJUDY SIEGEL-ITZKOVICHUpdated:
![Nano-antibodies [in purple] settle on the spike of the corona virus.](https://images.jpost.com/image/upload/f_auto,fl_lossy/q_auto/c_fill,g_faces:center,h_720,w_1280/481436 "Nano-antibodies [in purple] settle on the spike of the corona virus.")